Stay updated on Daratumumab for Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for a completed Phase II study of daratumumab in transplant-eligible patients with multiple myeloma is now displayed, including its protocol, study measures, eligibility criteria, and supporting documents.
    Difference
    62%
    Check dated 2026-11-10T06:25:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T02:05:06.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition-related updates and says federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-27T02:12:16.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T03:56:54.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T07:31:28.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision metadata was added (Revision: v3.7.0). Several document-related items and institution references were removed from the page, impacting access to study documents and related links.
    Difference
    21%
    Check dated 2026-09-22T02:43:59.000Z thumbnail image

Stay in the know with updates to Daratumumab for Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.